In type 2 diabetic rats, elevated MDA levels and decreased TAC, SOD, and CAT occurred, and NSSP treatment (35, 70, and 140 mg/kg for 4 weeks, orally) improved oxidant/anti-oxidant balance (158). This evidence concerns the gene SOD1 and type 2 diabetes mellitus.